clobetasone butyrate (Eumovate)

Subscribe to Selected New Research on clobetasone butyrate

44 relevant articles (8 outcomes, 13 trials/studies) found for this Bio-Agent

Also Known As:

Eumovate; 21-chloro-11-dehydro-betamethasone-17-butyrate; Emovate; Trimovate; clobetasone 17-butyrate

Relationship Network

Bio-Agent Context: Research Results

Polycyclic Compounds: 58

Steroids: 13712

Fluorinated Steroids: 18

Betamethasone: 926

Clobetasol: 245

clobetasone butyrate: 44

Experts

1.	Lim, Regina P R: 1 article (11/2006)
2.	Abdullah, Anthony: 1 article (11/2006)
3.	Cohen, Stuart N: 1 article (11/2006)
4.	Paul, C Jose: 1 article (11/2006)
5.	Goustas, P: 1 article (12/2001)
6.	Parneix-Spake, A: 1 article (12/2001)
7.	Green, R: 1 article (12/2001)
8.	Tang, A: 1 article (02/2001)
9.	David, N: 1 article (02/2001)
10.	Horton, L W: 1 article (02/2001)

Related Diseases

1.	Psoriasis (Pustulosis Palmaris et Plantaris) 01/01/1982 - "In a parallel group design, and using a 'blind evaluator' technique, alclometasone cream 0.05% and clobetasone butyrate cream 0.5% applied twice a day for 21 days were compared in thirty-one patients presenting with psoriasis" 01/01/1976 - "In a second open trial, 29 adults with eczema or psoriasis were treated twice daily with clobetasone butyrate for 1 week: lesions in 10 patients remained static, 12 improved, and 7 were cleared" 01/01/1977 - "Clobetasone butyrate ointment has been shown to be more effective in treating psoriasis and eczema than flurandrenolone ointment yet to cause less epidermal thinning in a human experimental model" 01/01/1976 - "Studies were carried out to assess the effectiveness of clobetasone butyrate in treating eczema and psoriasis, and to determine if the compound had any effect on plasma cortisol levels" 10/01/1998 - "The mean percentage change in PASI (psoriasis area and severity index) was -40.6 in the calcipotriol/vehicle group, -48.3 in the calcipotriol/calcipotriol group, -53.7 in the calcipotriol/clobetasone 17-butyrate group and -57.5 in the calcipotriol/betamethasone 17-valerate group" Order ALL the reference details at left...
2.	Eczema 01/01/1976 - "In a second open trial, 29 adults with eczema or psoriasis were treated twice daily with clobetasone butyrate for 1 week: lesions in 10 patients remained static, 12 improved, and 7 were cleared" 01/01/1977 - "Clobetasone butyrate ointment has been shown to be more effective in treating psoriasis and eczema than flurandrenolone ointment yet to cause less epidermal thinning in a human experimental model" 01/01/1976 - "Studies were carried out to assess the effectiveness of clobetasone butyrate in treating eczema and psoriasis, and to determine if the compound had any effect on plasma cortisol levels" 01/01/1979 - "Clobetasone butyrate and hydrocortisone butyrate in the treatment of eczema: a double-blind comparison." 06/01/2003 - "Eumovate(TM) (clobetasone butyrate 0.05%) cream has recently been made available as a pharmacy medication for the short-term management of acute eczema and allergic dermatitis by adults and children aged 10 or older, based on evidence derived from clinical trials involving over 3500 patients" Order ALL the reference details at left...
3.	Uveitis 11/01/1979 - "We present the results of a double-blind trial comparing the efficacy of betamethasone phosphate 0.1%, clobetasone butyrate 0.1%, and placebo in the treatment of acute unilateral nongranulomatous uveitis" 01/01/1979 - "The results are presented of a double-blind trial comparing the efficacy of betamethasone phosphate 0.1 per cent, clobetasone butyrate 0.1 per cent, and placebo in the treatment of acute unilateral non-granulomatous uveitis" 11/01/1979 - "The 2 steroids were equally comparable in improvement of the patients' symptoms, though betamethasone phosphate was significantly more effective than clobetasone butyrate in improving the ocular signs of uveitis" 01/01/1979 - "The two steroids gave comparable results in improvement of the patients' symptoms, although betamethasone phosphate was significantly more effective than clobetasone butyrate in improving the ocular signs of uveitis" Order ALL the reference details at left...
4.	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 03/01/1993 - "The results show the clinical efficacy of clobetasone butyrate in the treatment of pollen-induced allergic conjunctivitis." 09/01/1981 - "Patients' preference for the treatment of seasonal allergic conjunctivitis was markedly in favour of clobetasone butyrate (P less than 0.001)." 09/01/1981 - "A clinical comparison of topical clobetasone butyrate and sodium cromoglycate in allergic conjunctivitis." 09/01/1981 - "Clobetasone butyrate (0.1%), a new topical corticosteroid eye preparation for the treatment of ocular inflammation, has been compared with sodium cromoglycate (2%) eye drops in thirty-nine patients experiencing allergic conjunctivitis during the hay fever season" Order ALL the reference details at left...
5.	Pemphigus (Pemphigus Vulgaris) 11/01/2006 - "Equal efficacy of topical tacrolimus and clobetasone butyrate in pemphigus foliaceus." Order ALL the reference details at left...

Related Drugs and Biologics

1.	betamethasone sodium phosphate
2.	Flurandrenolone (Haelan)
3.	Hydrocortisone (Cortisol)
4.	Butyrates (Butyrate)
5.	Tacrolimus (Prograf)
6.	clobetasone butyrate (Eumovate)
7.	Ophthalmic Solutions (Eye Drops)
8.	Betamethasone (Celestone)
9.	Steroids
10.	Betamethasone 17-Valerate (Betamethasone 17 Valerate)

Related Therapies and Procedures

1.	Aftercare (After-Treatment)
2.	Cataract Extraction

Best Treatments:
Research Summary Report
on Psoriasis

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 1265 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>